Search details
1.
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Lancet
; 2024 May 16.
Article
in English
| MEDLINE | ID: mdl-38768626
2.
Ethical Justification for Deferral of Consent in the AcT Trial for Acute Ischemic Stroke.
Stroke
; 53(7): 2420-2423, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35603597
3.
Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
Stroke
; 46(3): 769-74, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25677596
4.
A Randomized Controlled Trial of Tenecteplase Versus Standard of Care for Minor Ischemic Stroke with Proven Occlusion (TEMPO-2): Rational and design of a multicenter, randomized open-label clinical trial.
Int J Stroke
; : 17474930241253702, 2024 May 17.
Article
in English
| MEDLINE | ID: mdl-38676572
5.
Tissue Window in Stroke Thrombolysis study (TWIST): a safety study.
Can J Neurol Sci
; 40(1): 17-20, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23250122
6.
Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial.
CMAJ Open
; 9(2): E693-E702, 2021.
Article
in English
| MEDLINE | ID: mdl-34145052
7.
3-Tesla versus 1.5-Tesla magnetic resonance diffusion and perfusion imaging in hyperacute ischemic stroke.
Cerebrovasc Dis
; 24(4): 361-8, 2007.
Article
in English
| MEDLINE | ID: mdl-17690549
Results
1 -
7
de 7
1
Next >
>>